Laboratorio Reig Jofre (LTS:0RB1) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RB1 Laboratorio Reig Jofre SA LTS:0RB1
81 GF Score
Price €2.61
GF Value €2.67
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Laboratorio Reig Jofre Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Laboratorio Reig Jofre  (LTS:0RB1) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Related Terms


Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Chart

Laboratorio Reig Jofre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.94 0.93

Laboratorio Reig Jofre Quarterly Data
Mar21 Jun21 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 1.01 0.93 0.88 0.95

LTS:0RB1 vs ZTS, UTHR, VTRS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Reig Jofre Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio falls into.


LTS:0RB1
81GF Score
Laboratorio Reig Jofre SA LTS:0RB1
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Laboratorio Reig Jofre's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Laboratorio Reig Jofre's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.723/131.3300*131.3300
=2.723

Current CPI (Jun. 2026) = 131.3300.

Laboratorio Reig Jofre Quarterly Data

Book Value per Share CPI Adj_Book
201309 4.667 100.597 6.093
201312 4.663 101.306 6.045
201403 4.754 100.139 6.235
201409 4.752 100.441 6.213
201412 1.875 100.251 2.456
201503 1.965 99.474 2.594
201509 2.041 99.559 2.692
201603 2.033 98.638 2.707
201803 2.244 102.122 2.886
201806 2.250 104.165 2.837
201809 2.245 103.818 2.840
201812 2.312 104.193 2.914
201903 2.344 103.488 2.975
201906 2.324 104.612 2.918
201909 2.312 103.905 2.922
201912 2.354 105.015 2.944
202003 2.385 103.469 3.027
202006 2.399 104.254 3.022
202009 2.415 103.521 3.064
202012 2.419 104.456 3.041
202103 2.469 104.857 3.092
202106 2.468 107.102 3.026
202109 2.460 107.669 3.001
202112 2.457 111.298 2.899
202209 2.459 117.221 2.755
202212 2.503 117.650 2.794
202303 118.948 0.000
202306 2.528 120.278 2.760
202309 2.567 121.343 2.778
202312 2.592 121.300 2.806
202403 2.626 122.762 2.809
202406 2.617 124.409 2.763
202409 2.649 123.121 2.826
202412 2.672 124.753 2.813
202503 2.729 125.531 2.855
202506 2.659 127.251 2.744
202509 2.666 126.840 2.760
202512 2.708 128.400 2.770
202603 2.746 129.860 2.777
202606 2.723 131.330 2.723

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Laboratorio Reig Jofre (LTS:0RB1) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Reig Jofre stock appears to be undervalued. The current stock price of €2.61 is trading 2.2% below its estimated GF Value™ of €2.67. GuruFocus considers Laboratorio Reig Jofre to be Fairly Valued.

Key valuation signals for LTS:0RB1:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €2.67 vs. price of €2.61 (2.2% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the LTS:0RB1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laboratorio Reig Jofre Business Description

Other Exchanges RJF:SpainFEQ1:Germany
Address Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
81GF Score

Get the complete analysis for LTS:0RB1

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.61
Price
€2.67
GF Value